Patient satisfaction with antidepressants: An Internet-based study

Journal of Affective Disorders

Volumn 107, Issue 1-3, 2008, Pages 155-160

  Shigemura, Jun ^a   Sato, Yutaka ^a   Yoshino, Aihide ^a   Nomura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Antidepressant; Patient satisfaction; Polypharmacy; Selective serotonin reuptake inhibitor (SSRI); Serotonin noradrenaline reuptake inhibitor (SNRI); Tricyclic antidepressant (TCA)

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CLOMIPRAMINE; DOSULEPIN; FLUVOXAMINE; IMIPRAMINE; LITHIUM; MAPROTILINE; MIANSERIN; MILNACIPRAN; NORTRIPTYLINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TECIPTILINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; INTERNET; JAPANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT SATISFACTION; POLYPHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; UNSPECIFIED SIDE EFFECT;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOPROPANES; DATA COLLECTION; DEPRESSIVE DISORDER, MAJOR; FLUVOXAMINE; HUMANS; INTERNET; JAPAN; LOGISTIC MODELS; PAROXETINE; PATIENT SATISFACTION; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS;

EID: 39649104604     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.08.019     Document Type: Article

References (18)

1. Anderson I.M. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J. Affect. Disord. 58 (2000) 19-36
2. Bollini P., Pampallona S., Tibaldi G., Kupelnick B., and Munizza C. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br. J. Psychiatry 174 (1999) 297-303
3. Bultman D.C., and Svarstad B.L. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J. Am. Pharm. Assoc. (Wash) 42 (2002) 36-43
4. Caccia S. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin. Pharmacokinet. 34 (1998) 281-302
5. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur. Neuropsychopharmacol. 13 Suppl 3 (2003) S69-S75
6. Demyttenaere K., Enzlin P., Dewe W., Boulanger B., De Bie J., De Troyer W., and Mesters P. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J. Clin. Psychiatry 62 Suppl 22 (2001) 30-33
7. DeVane C.L. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J. Clin. Psychiatry 64 Suppl 18 (2003) 14-19
8. Frye M.A., Ketter T.A., Leverich G.S., Huggins T., Lantz C., Denicoff K.D., and Post R.M. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J. Clin. Psychiatry 61 (2000) 9-15
9. Granger A.L., Fehnel S.E., Hogue S.L., Bennett L., and Edin H.M. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J. Affect. Disord 90 (2006) 217-221
10. Higuchi T. The guideline for the treatment of mood disorders in USA and Japan. Nippon Rinsho 59 (2001) 1499-1506
11. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., Paulus M.P., Kunovac J.L., Leon A.C., Mueller T.I., Rice J.A., and Keller M.B. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch. Gen. Psychiatry 55 (1998) 694-700
12. Keene M.S., Eaddy M.T., Mauch R.P., Regan T.S., Shah M., and Chiao E. Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs). Curr. Med. Res. Opin 21 (2005) 1651-1658
13. Kingsbury S.J., Yi D., and Simpson G.M. Psychopharmacology: rational and irrational polypharmacy. Psychiatr. Serv. 52 (2001) 1033-1036
14. Lopez-Ibor J.J., and Conesa A. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder. Curr. Med. Res. Opin. 20 (2004) 855-860
15. Macgillivray S., Arroll B., Hatcher S., Ogston S., Reid I., Sullivan F., Williams B., and Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. B.M.J 326 (2003) 1014-1017
16. Puech A., Montgomery S.A., Prost J.F., Solles A., and Briley M. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int. Clin. Psychopharmacol. 12 (1997) 99-108
17. Rhodes S.D., Bowie D.A., and Hergenrather K.C. Collecting behavioural data using the world wide web: considerations for researchers. J. Epidemiol. Community Health 57 (2003) 68-73
18. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., and Murray C.J. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004) 386-392